Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072.
Article
CAS
PubMed
Google Scholar
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002, 288: 2709-2716.
Article
PubMed
Google Scholar
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ: The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010, 56: 1113-1132.
Article
PubMed
Google Scholar
Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Int Med. 2005, 165: 2644-2650.
Article
Google Scholar
Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J, Inter ACG: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005, 365: 1398-1405.
Article
PubMed
Google Scholar
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004, 109: 433-438.
Article
PubMed
Google Scholar
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752.
Article
PubMed
Google Scholar
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, et al: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003, 26: 3160-3167.
Article
PubMed
Google Scholar
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645.
Article
CAS
PubMed
Google Scholar
American Diabetes Association: Diabetes Care. 2010, 33 (Suppl 1): S62-S69.
Article
PubMed Central
Google Scholar
Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E, et al: Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007, 30: 2453-2457.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F: Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study. Diab Res Clin Pract. 2010, 87: 342-347.
Article
CAS
Google Scholar
Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, et al: The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona diabetes complications study. Diab Med. 2004, 21: 52-58.
Article
CAS
Google Scholar
Church TS, Thompson AM, Katzmarzyk PT, Sui X, Johannsen N, Earnest CP, Blair SN: Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men. Diabetes Care. 2009, 32: 1289-1294.
Article
PubMed
PubMed Central
Google Scholar
Popkin BM, Du S, Zhai F, Zhang B: Cohort Profile: The China Health and Nutrition Survey–monitoring and understanding socio-economic and health change in China, 1989–2011. Int J Epidemiol. 2010, 39: 1435-1440.
Article
PubMed
Google Scholar
Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care. 2004, 27: 1487-1495.
Article
PubMed
Google Scholar
Succurro E, Marini MA, Arturi F, Grembiale A, Fiorentino TV, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, et al: Usefulness of hemoglobin A1c as a criterion to define the metabolic syndrome in a cohort of italian nondiabetic white subjects. Am J Cardiol. 2011, 107: 1650-1655.
Article
CAS
PubMed
Google Scholar
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362: 1090-1101.
Article
CAS
PubMed
Google Scholar
Ong KL, Tso AW, Lam KS, Cherny SS, Sham PC, Cheung BM: Using glycosylated hemoglobin to define the metabolic syndrome in United States adults. Diabetes Care. 2010, 33: 1856-1858.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD, Phillips LS: Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010, 152: 770-777.
Article
PubMed
Google Scholar
Heianza Y, Arase Y, Fujihara K, Tsuji H, Saito K, Hsieh SD, Kodama S, Shimano H, Yamada N, Hara S, et al: High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8). Diab Med. 2012, 29: 1285-1290.
Article
CAS
Google Scholar
Bi Y, Zeng L, Zhu D, Yan J, Zhang Y, Tong G, Mu P, Shen S, Hu Y, Yu Q, et al: Association of beta-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. Diab Obes Metab. 2012, 14: 174-180.
Article
CAS
Google Scholar
Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B, American Diabetes A: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007, 30: 753-759.
Article
CAS
PubMed
Google Scholar
Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB: Tests of glycemia in diabetes. Diabetes Care. 2004, 27: 1761-1773.
Article
PubMed
Google Scholar
Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA: Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006, 55: 1430-1435.
Article
CAS
PubMed
Google Scholar
Faerch K, Pacini G, Nolan JJ, Hansen T, Tura A, Vistisen D: Impact of glucose tolerance status, Sex, and body size on glucose absorption patterns during OGTTs. Diabetes care. 2013, 36: 3691-3697.
Article
CAS
PubMed
PubMed Central
Google Scholar
Faerch K, Borch-Johnsen K, Vaag A, Jorgensen T, Witte DR: Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia. 2010, 53: 858-865.
Article
CAS
PubMed
Google Scholar
Williams JW, Zimmet PZ, Shaw JE, de Courten MP, Cameron AJ, Chitson P, Tuomilehto J, Alberti KG: Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter?. Diab Med. 2003, 20: 915-920.
Article
CAS
Google Scholar
Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care. 2003, 26: 881-885.
Article
PubMed
Google Scholar
Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359.
Article
PubMed
Google Scholar
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Emerging Risk Factors C, et al: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010, 375: 2215-2222.
Article
CAS
PubMed
Google Scholar
Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E: Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2006, 29: 1619-1625.
Article
CAS
PubMed
Google Scholar
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010, 362: 800-811.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, Tsuji H, Kodama S, Hsieh SD, Mori Y, Shimano H, et al: HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet. 2011, 378: 147-155.
Article
CAS
PubMed
Google Scholar
Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J: Performance of A1C for the classification and prediction of diabetes. Diabetes Care. 2011, 34: 84-89.
Article
CAS
PubMed
Google Scholar